GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0071356
|
BP
|
cellular response to tumor necrosis factor
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
TNFRSF21,
ASS1,
COL1A1,
APOB,
IL6,
EDN1,
ICAM1,
THBS1,
CXCL8,
CCL3,
CCL4,
TDGF1,
CCL2,
CCL5,
CD58,
VCAM1,
ZFP36,
RORA,
PCK1,
CHI3L1,
BRCA1,
ZFP36L2,
HDAC4,
ADAMTS12,
CCL20,
CCL8,
HAMP,
RELA,
ZFP36L1,
HYAL2,
RIPK1,
HDAC1,
KCNJ11,
POSTN,
ANKRD1,
PCK2,
ZFAND6,
PID1,
SFRP1,
TRPV1,
HAS2,
TANK,
ARHGEF2,
GPER1,
MAP3K5,
CIB1,
INPP5K,
SMPD4,
PPARGC1A,
ADAMTS7,
PYCARD,
KLF2
|
GO:0071359
|
BP
|
cellular response to dsRNA
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a double-stranded RNA stimulus.
|
NFKB1
|
GO:0071360
|
BP
|
cellular response to exogenous dsRNA
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus.
|
TLR3,
FLOT1,
RALB,
CAV1,
COLEC12,
MAVS
|
GO:0071361
|
BP
|
cellular response to ethanol
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.
|
CYBB,
ADCY7,
ITPR2,
TP53INP1
|
GO:0071363
|
BP
|
cellular response to growth factor stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
ANGPT2,
KLF4,
URI1,
PDGFB,
BGLAP,
ERBB2,
INSR,
TH,
PFN1,
THBS1,
SPARC,
SRD5A1,
TNFRSF1B,
DTYMK,
CTNNB1,
EMD,
STAT5B,
RACK1,
MDM2,
MAP2K5,
MAPK7,
RIPK1,
GAS6,
PPP2R5B,
TWIST1,
TWF2,
SFRP1,
FEZ1,
CIB1,
EHD4
|
GO:0071364
|
BP
|
cellular response to epidermal growth factor stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
|
SNAI2,
ZPR1,
EGFR,
COL1A1,
ERBB2,
GSTP1,
TDGF1,
ZFP36,
CAD,
AKT1,
MCM7,
ID1,
IQGAP1,
ZFP36L2,
SOX9,
STAT5B,
EEF1A1,
ZFP36L1,
INPP5K,
GAREM1,
ERRFI1
|
GO:0071371
|
BP
|
cellular response to gonadotropin stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gonadotropin stimulus.
|
WT1,
LHCGR,
PAX8,
NSMF,
GATA6,
SLC5A5
|
GO:0071372
|
BP
|
cellular response to follicle-stimulating hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a follicle-stimulating hormone stimulus.
|
INHBA,
NOTCH1,
GCLC,
GCLM,
STAR,
EFNA5,
HMGCS1,
PPARGC1A
|
GO:0071373
|
BP
|
cellular response to luteinizing hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a luteinizing hormone stimulus.
|
CCNA2,
STAR
|
GO:0071374
|
BP
|
cellular response to parathyroid hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a parathyroid hormone stimulus.
|
PRKACA,
HDAC4,
MEF2C,
SOST
|
GO:0071375
|
BP
|
cellular response to peptide hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
CYP11A1,
EDN1,
FYN,
CYP11B1,
XBP1,
CYP11B2,
NFKB1,
CSK,
MDM2,
CAV1,
RELA,
ZFP36L1,
GPER1
|
GO:0071376
|
BP
|
cellular response to corticotropin-releasing hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticotropin-releasing hormone stimulus. Corticotropin-releasing hormone is a peptide hormone involved in the stress response.
|
NR4A1,
NR4A2,
NR4A3
|
GO:0071377
|
BP
|
cellular response to glucagon stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucagon stimulus.
|
GNG7,
ADCY3,
ADCY9,
ASS1,
GCG,
PRKAR1A,
PRKAR2A,
GNB3,
PRKACA,
PRKAR2B,
PCK1,
GNG4,
ADCY7,
GNG11,
GNB1,
GNB2,
GNG5
|
GO:0071378
|
BP
|
cellular response to growth hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth hormone stimulus. Growth hormone is a peptide hormone that binds to the growth hormone receptor and stimulates growth.
|
STAR
|
GO:0071379
|
BP
|
cellular response to prostaglandin stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin stimulus.
|
APOB,
AKR1C3
|
GO:0071380
|
BP
|
cellular response to prostaglandin E stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
|
TNFSF4,
AKT1,
PTGER4,
PPARG,
PTGER2,
PRKAA2,
GNB1,
SFRP1
|
GO:0071383
|
BP
|
cellular response to steroid hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus.
|
NPC1,
URI1,
NR3C1,
ATP1A2,
MGARP
|
GO:0071384
|
BP
|
cellular response to corticosteroid stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.
|
AKR1C3
|
GO:0071385
|
BP
|
cellular response to glucocorticoid stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects.
|
ANXA1,
EDN1,
GSTP1,
ZFP36,
SSTR5,
ZFP36L2,
STC1,
ZFP36L1,
HEY1
|
GO:0071386
|
BP
|
cellular response to corticosterone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosterone stimulus. Corticosterone is a 21 carbon steroid hormone of the corticosteroid type, produced in the cortex of the adrenal glands. In many species, corticosterone is the principal glucocorticoid, involved in regulation of fuel metabolism, immune reactions, and stress responses.
|
FOXO3,
ATP2B1
|
GO:0071387
|
BP
|
cellular response to cortisol stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cortisol stimulus. Cortisol is the major natural glucocorticoid synthesized in the zona fasciculata of the adrenal cortex; it affects the metabolism of glucose, protein, and fats and has appreciable mineralocorticoid activity. It also regulates the immune system and affects many other functions.
|
KLF9
|
GO:0071389
|
BP
|
cellular response to mineralocorticoid stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mineralocorticoid stimulus. Mineralocorticoids are hormonal C21 corticosteroids synthesized from cholesterol and characterized by their similarity to aldosterone. Mineralocorticoids act primarily on water and electrolyte balance.
|
EDN1,
GPER1
|
GO:0071391
|
BP
|
cellular response to estrogen stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics.
|
ESR1,
SERPINB9,
MDM2,
SFRP1,
WBP2
|
GO:0071392
|
BP
|
cellular response to estradiol stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
RAMP3,
AIFM1,
EGFR,
ESR1,
IL6,
H2AFZ,
ITGA2,
SRD5A1,
CCNA2,
IL10,
SSTR1,
NRIP1,
HSF1,
HNRNPD,
SFRP1,
GPER1,
PPARGC1A,
RUVBL2,
NCOA3
|
GO:0071394
|
BP
|
cellular response to testosterone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a testosterone stimulus.
|
ROCK2,
SRD5A1,
ELK1,
AACS
|
GO:0071395
|
BP
|
cellular response to jasmonic acid stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a jasmonic acid stimulus.
|
AKR1C3,
AKR1C2,
AKR1C1
|
GO:0071396
|
BP
|
cellular response to lipid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus.
|
BAD
|
GO:0071397
|
BP
|
cellular response to cholesterol
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
LRP6,
ABCA1,
INHBA,
GPLD1,
HMGCS1,
PTCH1,
AACS
|
GO:0071398
|
BP
|
cellular response to fatty acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.
|
LDLR,
EDN1,
XRCC5,
CCNB1,
NME1,
CREB1,
NME2,
PTAFR,
SREBF1,
CPT1A,
E2F1,
PDK4,
PID1,
SMARCD1,
NR1H4,
OR51E2
|
GO:0071400
|
BP
|
cellular response to oleic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oleic acid stimulus.
|
ASS1,
DGAT2
|
GO:0071401
|
BP
|
cellular response to triglyceride
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a triglyceride stimulus.
|
GPLD1
|
GO:0071403
|
BP
|
cellular response to high density lipoprotein particle stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a high density lipoprotein particle stimulus.
|
CCL2
|
GO:0071404
|
BP
|
cellular response to low-density lipoprotein particle stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus.
|
NPC1,
ITGB2,
ITGB1,
CD36,
CD9,
SYK,
CD81
|
GO:0071407
|
BP
|
cellular response to organic cyclic compound
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
AXIN1,
SMAD9,
PAK3,
TGFB1,
TNF,
IL1B,
CYP1A1,
ALPL,
HSP90AB1,
LGALS1,
GLI2,
CCL3,
BMP2,
CCL2,
CCL5,
CCNB1,
CEBPB,
ITGA6,
IGFBP5,
AKT1,
STAT3,
CDKN1B,
RAE1,
TMF1,
PAK2,
IL18,
CASP8,
ANKRD1,
CYP1B1,
SMAD5,
BTRC
|
GO:0071409
|
BP
|
cellular response to cycloheximide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes.
|
KLF4,
KLF2
|
GO:0071417
|
BP
|
cellular response to organonitrogen compound
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond.
|
NR1H4
|
GO:0071418
|
BP
|
cellular response to amine stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amine stimulus. An amine is a compound formally derived from ammonia by replacing one, two or three hydrogen atoms by hydrocarbyl groups.
|
ASS1
|
GO:0071420
|
BP
|
cellular response to histamine
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a histamine stimulus. Histamine, the biogenic amine 2-(1H-imidazol-4-yl)ethanamine, is involved in local immune responses as well as regulating physiological function in the gut and acting as a neurotransmitter.
|
HRH1
|
GO:0071421
|
BP
|
manganese ion transmembrane transport
|
A process in which a manganese ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
|
ZP3,
SLC11A1,
SLC11A2
|
GO:0071425
|
BP
|
hematopoietic stem cell proliferation
|
The expansion of a hematopoietic stem cell population by cell division. A hematopoietic stem cell is a stem cell from which all cells of the lymphoid and myeloid lineages develop.
|
WNT5A,
RUNX1,
SART3,
SHB,
NKAP,
WNT2B
|
GO:0071426
|
BP
|
ribonucleoprotein complex export from nucleus
|
The directed movement of a ribonucleoprotein complex from the nucleus to the cytoplasm.
|
NUP62,
NUP62CL
|
GO:0071435
|
BP
|
potassium ion export
|
The directed movement of potassium ions out of a cell or organelle.
|
KCNH2,
KCNIP2
|
GO:0071442
|
BP
|
positive regulation of histone H3-K14 acetylation
|
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to histone H3 at position 14 of the histone.
|
WBP2,
NAP1L2
|
GO:0071447
|
BP
|
cellular response to hydroperoxide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydroperoxide stimulus. Hydroperoxides are monosubstitution products of hydrogen peroxide, HOOH.
|
CD36,
PRKCD,
OXR1,
TP53INP1
|
GO:0071449
|
BP
|
cellular response to lipid hydroperoxide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid hydroperoxide stimulus. Lipid hydroperoxide is the highly reactive primary oxygenated products of polyunsaturated fatty acids.
|
MGST1
|
GO:0071451
|
BP
|
cellular response to superoxide
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a superoxide stimulus. Superoxide is the anion, oxygen-, formed by addition of one electron to dioxygen (O2) or any compound containing the superoxide anion.
|
GLRX2
|
GO:0071455
|
BP
|
cellular response to hyperoxia
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension.
|
FAS,
PPARG,
CAV1,
FOXO1,
DNMT3B
|
GO:0071456
|
BP
|
cellular response to hypoxia
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
KCNK3,
MDM4,
FOXO3,
BNIP3L,
STC2,
LMNA,
S100B,
TP53,
EDN1,
ICAM1,
P4HB,
HMOX1,
BCL2,
CCNB1,
SLC2A4,
VEGFA,
CCNA2,
MT3,
AKT1,
PTGS2,
RORA,
PCK1,
IRAK1,
STC1,
NPEPPS,
PTEN,
GNB1,
ADAM8,
MDM2,
E2F1,
PPARD,
ZFP36L1,
BNIP3,
EIF4EBP1,
PMAIP1,
ANKRD1,
TWIST1,
PTGIS,
HIF1A,
CPEB2,
SIRT2,
SFRP1,
NDNF,
MGARP,
NDRG1,
GATA6,
BAD,
FAM162A,
ERO1A,
SLC29A1,
EPAS1,
PINK1,
HIPK2,
RGCC,
SUV39H2,
FMN2,
PPARGC1A,
TRPC6,
HYOU1,
TBL2
|
GO:0071459
|
BP
|
protein localization to chromosome, centromeric region
|
Any process in which a protein is transported to, or maintained at, the centromeric region of a chromosome.
|
RB1,
CENPA,
GSG2
|
GO:0071460
|
BP
|
cellular response to cell-matrix adhesion
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of cell-matrix adhesion.
|
GSTP1,
SKP2
|
GO:0071461
|
BP
|
cellular response to redox state
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating redox state. Redox state refers to the balance of oxidized versus reduced forms of electron donors and acceptors in an organelle, cell or organ; plastoquinone, glutathione (GSH/GSSG), and nicotinamide nucleotides (NAD+/NADH and NADP+/NADPH) are among the most important.
|
ARHGDIB
|
GO:0071464
|
BP
|
cellular response to hydrostatic pressure
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrostatic pressure stimulus. Hydrostatic pressure is the force acting on an object in a system where the fluid is at rest (as opposed to moving). The weight of the fluid above the object creates pressure on it.
|
PKD2
|
GO:0071466
|
BP
|
cellular response to xenobiotic stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a xenobiotic compound stimulus. Xenobiotic compounds are compounds foreign to living organisms.
|
RB1,
MCM7,
E2F1
|
GO:0071467
|
BP
|
cellular response to pH
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus. pH is a measure of the acidity or basicity of an aqueous solution.
|
GNA11,
GPLD1
|
GO:0071468
|
BP
|
cellular response to acidic pH
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pH stimulus with pH < 7. pH is a measure of the acidity or basicity of an aqueous solution.
|
RAB11B,
TRPV1,
CHP1,
IMPACT
|
GO:0071470
|
BP
|
cellular response to osmotic stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of solutes outside the organism or cell.
|
DDX3X,
SLC2A4,
RELB,
PKD2,
TRPV4
|
GO:0071472
|
BP
|
cellular response to salt stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating an increase or decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
CAPN3,
ZFP36L1
|
GO:0071474
|
BP
|
cellular hyperosmotic response
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hyperosmotic environment, i.e. an environment with a higher concentration of solutes than the organism or cell.
|
ARHGEF2,
ERRFI1
|
GO:0071475
|
BP
|
cellular hyperosmotic salinity response
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, an increase in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
XRCC5
|
GO:0071476
|
BP
|
cellular hypotonic response
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a hypotonic environment, i.e. an environment with a lower concentration of solutes than the organism or cell.
|
TSPO,
MYLK,
TRPV4,
CAB39
|
GO:0071477
|
BP
|
cellular hypotonic salinity response
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of detection of, or exposure to, a decrease in the concentration of salt (particularly but not exclusively sodium and chloride ions) in the environment.
|
TRPV4
|
GO:0071478
|
BP
|
cellular response to radiation
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
HSF1,
ADIRF
|
GO:0071479
|
BP
|
cellular response to ionizing radiation
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
|
SNAI2,
RAD1,
TGFB1,
TP53,
GADD45A,
EEF1D,
CDKN1A,
BLM,
RHOB,
GRB2,
RAD51,
SPIDR,
MAPK14,
IFI16,
SWI5,
RAD9B,
NET1,
TANK,
RAD51AP1,
RAD9A,
RHNO1,
ECT2,
INTS7
|
GO:0071480
|
BP
|
cellular response to gamma radiation
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
|
KDM1A,
CRYAB,
XRCC5,
H2AFX,
EGR1,
ELK1,
YAP1,
RAD51,
TSPYL5,
NOX4
|
GO:0071481
|
BP
|
cellular response to X-ray
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of X-ray radiation. An X-ray is a form of electromagnetic radiation with a wavelength in the range of 10 nanometers to 100 picometers (corresponding to frequencies in the range 30 PHz to 3 EHz).
|
XRCC5,
HAMP,
NIPBL,
SFRP1,
NUCKS1
|
GO:0071482
|
BP
|
cellular response to light stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light.
|
OPN1SW,
OPN3
|
GO:0071492
|
BP
|
cellular response to UV-A
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-A radiation stimulus. UV-A radiation (UV-A light) spans the wavelengths 315 to 400 nm.
|
MME,
PPID
|
GO:0071493
|
BP
|
cellular response to UV-B
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-B radiation stimulus. UV-B radiation (UV-B light) spans the wavelengths 280 to 315 nm.
|
MME,
CDKN1A,
HYAL2,
STK11
|
GO:0071494
|
BP
|
cellular response to UV-C
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-C radiation stimulus. UV-C radiation (UV-C light) spans the wavelengths 100 to 280 nm.
|
MDM2,
IMPACT,
POLH
|
GO:0071498
|
BP
|
cellular response to fluid shear stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fluid shear stress stimulus. Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface.
|
HDAC3,
MTSS1,
CA2,
PTGS2,
TFPI2,
MEF2C,
PKD2,
HAS2
|
GO:0071499
|
BP
|
cellular response to laminar fluid shear stress
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers.
|
KLF4,
ASS1,
SREBF2,
MAP2K5,
MAPK7,
KLF2
|
GO:0071502
|
BP
|
cellular response to temperature stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus.
|
HTR2B,
TRPV1
|
GO:0071504
|
BP
|
cellular response to heparin
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heparin stimulus.
|
SLIT2,
EGR1,
SOX9,
SFRP1
|
GO:0071506
|
BP
|
cellular response to mycophenolic acid
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mycophenolic acid stimulus.
|
PDGFB,
EGR1
|
GO:0071514
|
BP
|
genetic imprinting
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules by a mechanism that is mediated by DNA, is mitotically or meiotically heritable, or is stably self-propagated in the cytoplasm of a resting cell, and does not entail a change in DNA sequence.
|
CDKN1C,
GNAS,
GNAS
|
GO:0071526
|
BP
|
semaphorin-plexin signaling pathway
|
A series of molecular signals generated as a consequence of a semaphorin receptor (composed of a plexin and a neurophilin) binding to a semaphorin ligand.
|
NRP1,
PLXNB2,
SEMA3E,
PLXNA2,
FARP2,
SEMA3D,
MET,
FLNA,
PLXNA3,
ARHGDIA,
RAC1,
SEMA3B,
SEMA5A,
SEMA3A,
SEMA6D,
SEMA3C,
SEMA6A,
SEMA4A,
SEMA6B,
PLXND1
|
GO:0071529
|
BP
|
cementum mineralization
|
The process in which calcium salts, mainly carbonated hydroxyapatite, are deposited into the initial acellular cementum.
|
ALPL
|
GO:0071539
|
BP
|
protein localization to centrosome
|
A process in which a protein is transported to, or maintained at, the centrosome.
|
AURKA,
CSNK1D,
DCTN2,
PCM1,
STIL,
CCDC14,
HOOK3,
PIBF1,
SPAG5,
CEP83
|
GO:0071542
|
BP
|
dopaminergic neuron differentiation
|
The process in which a neuroblast acquires the specialized structural and functional features of a dopaminergic neuron, a neuron that secretes dopamine.
|
LRP6,
VEGFA,
OTX2,
NR4A2,
HIF1A,
SFRP1
|
GO:0071543
|
BP
|
diphosphoinositol polyphosphate metabolic process
|
The chemical reactions and pathways involving a diphosphoinositol polyphosphate, 1,2,3,4,5,6-cyclohexanehexol with one or more diphosphate groups and multiple monophosphate groups attached.
|
NUDT10,
NUDT11
|
GO:0071544
|
BP
|
diphosphoinositol polyphosphate catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a diphosphoinositol polyphosphate, 1,2,3,4,5,6-cyclohexanehexol with one or more diphosphate groups and multiple monophosphate groups attached.
|
NUDT3
|
GO:0071548
|
BP
|
response to dexamethasone
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
FOXO3,
EDN1,
PCNA,
PTAFR,
PCK2
|
GO:0071549
|
BP
|
cellular response to dexamethasone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
MSTN,
EGFR,
ASS1,
TGFB1,
IL6,
CCL2,
SRD5A1,
SERPINF1,
STAR,
AGTR2,
CASP9,
RPL32,
HNRNPU,
FOXO1,
FBXO32,
SMYD3,
DNMT3B,
ERRFI1
|
GO:0071550
|
BP
|
death-inducing signaling complex assembly
|
A process of protein complex assembly in which the arrangement and bonding together of the set of components that form the protein complex is mediated by a death domain (DD) interaction, as part of the extrinsic apoptotic signaling pathway.
|
TNF,
RAF1,
FADD,
RIPK1,
CASP8,
TRADD
|
GO:0071554
|
BP
|
cell wall organization or biogenesis
|
A process that results in the biosynthesis of constituent macromolecules, assembly, arrangement of constituent parts, or disassembly of a cell wall.
|
SPATA20
|
GO:0071557
|
BP
|
histone H3-K27 demethylation
|
The modification of histone H3 by the removal of a methyl group from lysine at position 27 of the histone.
|
UTY,
KDM6A,
KDM7A
|
GO:0071559
|
BP
|
response to transforming growth factor beta
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
SMAD4,
RUNX3,
ZFHX3,
CITED1
|
GO:0071560
|
BP
|
cellular response to transforming growth factor beta stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
PDCD5,
SMAD7,
TGFB1,
PENK,
COL1A1,
EDN1,
CLEC3B,
FYN,
COL4A2,
WNT2,
FBN1,
SOX6,
TGFBR1,
WNT5A,
ZFP36L2,
LIMS1,
SOX9,
STAR,
CAV1,
MEF2C,
ZFP36L1,
HYAL2,
MAPK7,
PDE3A,
POSTN,
ANKRD1,
SFRP1,
HDAC2,
PDGFD,
NOX4,
PPARGC1A
|
GO:0071569
|
BP
|
protein ufmylation
|
Covalent attachment of the ubiquitin-like protein UFM1 to another protein.
|
UFM1,
UBA5
|
GO:0071577
|
BP
|
zinc II ion transmembrane transport
|
A process in which a zinc II ion is transported from one side of a membrane to the other by means of some agent such as a transporter or pore.
|
SLC39A6,
SLC39A14,
SLC30A8,
SLC30A1
|
GO:0071578
|
BP
|
zinc II ion transmembrane import
|
The directed movement of zinc II ions across a membrane into a cell or organelle.
|
SLC39A6,
SLC39A14,
SLC39A4,
SLC39A8,
SLC39A10
|
GO:0071584
|
BP
|
negative regulation of zinc ion transmembrane import
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of zinc ions (Zn2+) from one side of a membrane to the other.
|
SLC30A1
|
GO:0071585
|
BP
|
detoxification of cadmium ion
|
Any process that reduces or removes the toxicity of cadmium ion. These may include transport of cadmium away from sensitive areas and to compartments or complexes whose purpose is sequestration of cadmium ion.
|
SLC30A1
|
GO:0071586
|
BP
|
CAAX-box protein processing
|
The second process in a series of specific posttranslational modifications to the CAAX box region of CAAX box proteins, in which the last three amino acids of the protein (AAX) are removed by proteolysis.
|
RCE1
|
GO:0071593
|
BP
|
lymphocyte aggregation
|
The adhesion of one lymphocyte to one or more other lymphocytes via adhesion molecules.
|
RAC2
|
GO:0071596
|
BP
|
ubiquitin-dependent protein catabolic process via the N-end rule pathway
|
The chemical reactions and pathways resulting in the breakdown of a protein or peptide covalently tagged with ubiquitin, via the N-end rule pathway. In the N-end rule pathway, destabilizing N-terminal residues (N-degrons) in substrates are recognized by E3 ligases (N-recognins), whereupon the substrates are linked to ubiquitin and then delivered to the proteasome for degradation.
|
UBR3,
UBR1
|
GO:0071599
|
BP
|
otic vesicle development
|
The process whose specific outcome is the progression of the otic vesicle over time, from its formation to the mature structure. The otic vesicle is a transient embryonic structure formed during development of the vertebrate inner ear.
|
PAX8,
AHI1
|
GO:0071603
|
BP
|
endothelial cell-cell adhesion
|
The attachment of an endothelial cell to another endothelial cell via adhesion molecules.
|
JUP,
THBS4,
CYP1B1
|
GO:0071609
|
BP
|
chemokine (C-C motif) ligand 5 production
|
The appearance of chemokine (C-C motif) ligand 5 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
TUSC2
|
GO:0071621
|
BP
|
granulocyte chemotaxis
|
The movement of a granulocyte in response to an external stimulus.
|
ANXA1,
CCL3
|